Los Angeles, CA, United States of America

Dino Di Carlo

This inventor holds 59 USPTO granted patents and 35 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in Biomedical Engineering. Top assignee: University of California. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dino Di Carlo. Retrieved from https://idiyas.com/inventor/dino-di-carlo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 59 

% Patents Active = 94.9

 

 

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 302(Granted Patents)

Forward Citations (Not Self Cited) = 189(Dec 10, 2025)


Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Microporous Gels
Particle Manipulation
Cytometry
High-Throughput Screening
Ferrofluids
Cell Isolation
Biomedical Applications
Immunoassays
Digital Analysis
Droplet Formation
Cancer Cell Sorting
Cell Deformability
59 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Dino Di Carlo in the Field of Biomedical Engineering**

Introduction

Dino Di Carlo, based in Los Angeles, CA, is a distinguished inventor with a remarkable portfolio of 48 patents. His groundbreaking work primarily revolves around the development of advanced biomedical devices and methodologies that enhance the detection and analysis of rare cells. His inventions not only push the boundaries of technology but also hold significant implications for medical diagnostics and research.

Latest Patents

Among Di Carlo's latest patents are the innovative "Particle-drop structures and methods for making and using the same." This patent introduces sub-millimeter scale three-dimensional (3D) structures known as drop-carrier particles, which possess customizable chemical properties and functionality. The design allows for the selective association of a dispersed phase within the interior of these particles while a non-miscible continuous phase associates with the exterior. This compartmentalization enables the creation of sub-microliter-sized volumes ideal for single-molecule assays, single-cell assays, and other single-entity analyses.

Furthermore, Di Carlo's patent on the "Magnetically modulated computational cytometer and methods of use" showcases a significant advancement in cellular detection technology. This device employs magnetically modulated lensless speckle imaging combined with deep learning algorithms to detect rare cells in three dimensions. Its compact, cost-effective nature allows for high-throughput analysis in various biomedical applications, making it a valuable asset in the realm of health diagnostics.

Career Highlights

Dino Di Carlo has made a substantial impact in the field of biomedical engineering through his position at the University of California. His work exemplifies the intersection of cutting-edge technology and practical medical applications. With a strong emphasis on innovation, Di Carlo has contributed to the advancement of diagnostic tools, particularly in the detection and quantification of rare cells in bodily fluids.

Collaborations

Throughout his career, Di Carlo has collaborated with several notable professionals, including Daniel R Gossett and Henry T K Tse. These partnerships have fostered an environment of creativity and innovation, allowing for the development of groundbreaking technologies that enhance the capabilities of biomedical research.

Conclusion

Dino Di Carlo stands as a prominent figure in the innovation landscape, particularly within the biomedical sector. His extensive patent portfolio highlights his commitment to advancing technology that significantly impacts health diagnostics. Through his collaborations and work at the University of California, Di Carlo continues to push the boundaries of what's possible in the detection and analysis of rare biomedical entities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…